SLC2A1 and nervous system disorder: The metabolism and nerve disease–related KEGG pathways were enriched by GSEA analysis of SLC2A1 (Figure 3B, Table S8), suggesting its role in the metabolic disturbance of the brain and the neurological disorder in the nonsurvival patients.